Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor

J. Kodama, I. Hashimoto, N. Seki, A. Hongo, M. Yoshinouchi, H. Okuda, T. Kudo

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)


Background: The role of thrombospondin (TSP) in tumor progression remains controversial. The association of TSP with clinicopathological features regarding prognostic significance was examined in patients with epithelial ovarian tumor. Materials and Methods: Gene expression of TSP-1 and TSP-2 was assessed by reverse transcriptase-polymerase chain reaction in 6 borderline and 29 malignant epithelial ovarian tumors. Results: TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3%), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1%). In contrast, no specimen from the borderline epithelial ovarian tumors expressed TSP mRNA. TSP-1 expression was significantly higher in tumors with advanced stage, massive ascites, positive peritoneal cytology and high grade. TSP-2 expression was significantly higher in tumors with massive ascites. Patients exhibiting TSP-1 and -2 mRNA expression demonstrated a markedly poorer prognosis than those lacking TSP-1 and -2 mRNA expression. Conclusion: These findings provide evidence that TSP expression may be associated with an aggressive phenotype in this class of neoplasm.

Original languageEnglish
Pages (from-to)2983-2987
Number of pages5
JournalAnticancer research
Issue number4 B
Publication statusPublished - Nov 22 2001


  • Epithelial ovarian tumor
  • Prognosis
  • Thrombospondin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor'. Together they form a unique fingerprint.

Cite this